Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer
Genetic Testing and Molecular Biomarkers - United States
doi 10.1089/gtmb.2011.0298
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2012
Authors
Publisher
Mary Ann Liebert Inc